Article
Mechanisms involved in the HMGB1 modulation of tumor multidrug resistance (Review)
29 Jun 2023
Abstract excerpt
Tumor multidrug resistance (MDR) remains one of the most challenging barriers to successful cancer treatment. Several previous studies have suggested that high mobility group box 1 (HMGB1) may be a promising therapeutic target for overcoming cancer drug resistance. Emerging evidence has indicated that HMGB1 functions as a 'double‑edged sword' that plays both pro‑ and anti‑tumor roles in the development and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
